Septerna, Inc. (SEPN)
Septerna, Inc. (SEPN) from its SEC filings: 2025 revenue $46.0 million (+4174% vs the year before), net margin -106%, free cash flow $109.7 million. Insider trades, recent filings and a price chart. Free.
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Revenue (2025) | $46.0 million |
| Revenue growth | +4174% |
| Net income | -$48.9 million |
| Net margin | -106.4% |
| Free cash flow | $109.7 million |
| Diluted EPS | $-1.10 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +22376% |
| Cash | $84.7 million |
| Share count, 1 year | +5% |
| Fundamentals check | Strong fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-24. Education only, not financial advice.